Skip to main content

Past Event
30 October 2015


  • Lisa M. Ferri
    T +1 212 506 2340
  • Henninger S. Bullock
    T +1 212 506 2528
  • Rajesh De
    T +1 202 263 3366
  • Christopher M. Mikson, MD
    T +1 202 263 3157
  • Brian W. Nolan
    T +1 212 506 2517
  • Reb D. Wheeler
    T +1 212 506 2414



Symposium: Hot Topics in Life Sciences Law

The Hot Topics in Life Sciences Law symposium explored emerging issues and legal trends impacting the life sciences industry, including:

  • Successful partnering in drug development
  • Protecting drug franchises—litigation and patent office proceedings
  • Cybersecurity, privacy and data breaches
  • Internal investigations and ethical implications
  • Amarin v. FDA: the First Amendment and off-label marketing

Speakers included:

  • Lawrence Atinsky, Partner, Deerfield Management Company LLP
  • Raj De, Partner, Mayer Brown and former General Counsel for the US National Security Agency (NSA)
  • Hon. Joseph J. Farnan, Jr., (Ret.) U.S. District Court for the District of Delaware; Partner, Farnan LLP
  • Jeff Francer, Vice President and Senior Counsel, PhRMA
  • Janet Gongola, Patent Reform Coordinator, U.S. Patent and Trademark Office
  • Timothy Glynn, Miriam T. Rooney Professor of Law, Seton Hall Law School
  • Henry Hadad, Senior Vice President and Deputy General Counsel, Bristol-Myers Squibb
  • Edward Hartnett, Richard J Hughes Professor of Constitutional and Public Law and Service, Seton Hall Law
  • David Opderbeck, Professor of Law and Director of the Gibbons Institute of Law, Science & Technology, Seton Hall
  • Jordan Paradise, Schering-Plough Professor of Law, Seton Hall
  • Igor Proscurshim, Chief Scientific Officer, Recepta Biopharma SA
  • Jeff Warmke, Senior Vice President, Daiichi Sankyo Group

Event Materials


Status and Implications of Caronia and Other First Amendment Cases Regarding Off-Label Marketing

Internal Investigations in the Workplace: Hot Topics, Pitfalls, and Ethical Implications

Protecting Biopharmaceutical Innovation—Litigation and Patent Office Procedures

Biosimilars - Patent Process

Successful Partnering in Drug Development

For a write-up of this event please visit Seton Hall's website.

Please visit

The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.